Niacin Alternatives for Dyslipidemia: Fool’s Gold or Gold Mine? Part I: Alternative Niacin Regimens Richard L. DunbarHarsh Goel Nonstatin Drugs (E. deGoma, Section Editor) Open access 15 February 2016 Article: 11
Cardiac Rehabilitation in Patients with Established Atherosclerotic Vascular Disease: New Directions in the Era of Value-Based Healthcare Karen AspryWen-Chih WuElena Salmoirago-Blotcher Coronary Heart Disease (S. Virani and S. Naderi, Section Editors) 23 January 2016 Article: 10
Ethnic Minorities and Coronary Heart Disease: an Update and Future Directions J. Adam LeighManrique AlvarezCarlos J. Rodriguez Coronary Heart Disease (S. Virani and S. Naderi, Section Editors) 20 January 2016 Article: 9
The Role of Ezetimibe in the Treatment of Cardiovascular Disease Anandita AgarwalaZaid KajaniSalim S. Virani Coronary Heart Disease (S. Virani and S. Naderi, Section Editors) 20 January 2016 Article: 8
Cardiometabolic Effects of Glucagon-Like Peptide-1 Agonists Ashish SarrajuSun H. KimJoshua W. Knowles Nonstatin Drugs (E. deGoma, Section Editor) 19 January 2016 Article: 7
Women Versus Men: Is There Equal Benefit and Safety from Statins? Roda PlakogiannisSally A. Arif Statin Drugs (B. Wiggins, Section Editor) 18 January 2016 Article: 6